24 06 12 onemed

CS MEDICA Announces Strategic Partnership with OneMed

CS MEDICA Signs with OneMed for Enhanced Distribution and Marketing in Denmark

CS MEDICA is happy to announce a new strategic partnership with OneMed, a leading distributor in the healthcare sector. This collaboration marks a significant step in CS MEDICA’s newly adopted B2B2C strategy, which focuses on generating strategic partnerships for enhanced market access while continuing to prioritize its core values in research and development, production, compliance, and insights.

As part of the Asker Group, OneMed brings a robust distribution network and a deep understanding of the medical device landscape in Northern Europe. This partnership leverages OneMed’s extensive expertise and aligns with its vision of improving individuals’ health through effective healthcare solutions.
Extended Market Reach and Professional Expertise
With this partnership, CS MEDICA aims to utilize OneMed’s established channels and professional team to enhance the accessibility of its products in Denmark. This is the initial step in a potential expansion into other markets, reflecting a joint commitment to growth and excellence in healthcare provision.

Launch of New Branding and Packaging
With this partnership, CS MEDICA will launch new product packaging and brand content this October based on feedback from consumers and health professionals. These additions will further diversify our unique portfolio and address the evolving needs of the healthcare industry.

Seamless Transition for Existing Customers
OneMed will take over the distribution and marketing in Denmark from CS MEDICA’s subsidiary CANNORDIC, ensuring existing customers receive the high-quality service and products they expect. The aim is to make this transition as smooth as possible for all parties involved, additionally ensuring an uplift in service with the power of OneMed.

This partnership with OneMed represents a pivotal development in our strategy to expand access and deliver innovative solutions to the healthcare market while being able to focus on our core DNA as a MedTech. We are confident that OneMed’s expertise and network will help us reach more patients than we can,” says Lone Henriksen, CEO of CS MEDICA.

We chose CS MEDICA as our partner because they have successfully positioned themselves as leaders in compliant medical devices with CBD, which perfectly matches current market trends and regulations. Their proactive transition to MDR with a Notified Body sets them ahead of the competition, aligning perfectly with our mission to support superior health outcomes,” says Henning Rune Carlsen, Sales & Category Director of OneMed.

For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
Email: glh@cs-medica.com
Website: https://www.cs-medica.com/

OneMed, part of the Asker Group, is a leading provider of healthcare products and services across Northern Europe. It is dedicated to helping people achieve better health. With a vast network and expertise in medical compliance and distribution, OneMed ensures that healthcare solutions reach those most need them. For more information, please visit https://www.onemed.dk/ and https://www.asker.com/.

CS MEDICA Group, a Danish MedTech pioneer, specializes in developing evidence-based, CBD-integrated treatments for pain management, autoimmune and stress-related disorders. With a focus on patient-centric care, our products range from innovative R&D to registered over-the-counter substance-based medical devices and dermaceuticals. Our flagship CANNASEN® brand, alongside our own-label solutions, exemplifies our dedication to safe, high-quality treatments for both human and veterinary health globally. The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information, visit cs-medica.com and LinkedIn.

CANNORDIC A/S, a subsidiary of CS MEDICA Group, is a pioneering MedTech company specializing in innovative substance-based medical devices containing bioactive CBD. Our dedication to enhancing lives by integrating innovation, science, technology, and natural cannabis compounds positions it as a pioneer in the medical technology industry. The company ensures robust research, development, manufacturing, compliance, data insights, and commercialization processes with strong partners globally.